Cook, E B <br/><br/>
Olopatadine inhibits TNFalpha release from human conjunctival mast cells.  [electronic resource] 

 -  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology  May 2000 
 - 504-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1081-1206 
<br/><br/><label>Standard No.: </label>10.1016/S1081-1206(10)62513-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Anti-Idiotypic--pharmacology<br/>Conjunctiva--cytology<br/>Dibenzoxepins--pharmacology<br/>Dose-Response Relationship, Immunologic<br/>Humans<br/>Immunoglobulin E--immunology<br/>Mast Cells--immunology<br/>Olopatadine Hydrochloride<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors